Home results announces
 

Keywords :   


Tag: results announces

Ecopetrol Announces Its Results for the Third Quarter of 2013

2013-10-31 01:39:02| Jewelry - Topix.net

The financial results of the third quarter were the strongest of the past six quarters , driven by production growth, stable hydrocarbon prices and the devaluation of the Colombian peso.

Tags: of results quarter announces

 

Merck Announces Third-Quarter 2013 Financial Results

2013-10-28 12:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. 2013 Third-Quarter Non-GAAP EPS of $0.92, Excluding Certain Items; GAAP EPS of $0.38 Worldwide Sales were $11.0 Billion, a Decrease of 4 Percent Reflecting the Unfavorable Impact of Patent Expiries and a 2 Percent Negative Impact from Foreign Exchange Strong Growth in Vaccines and Immunology as well as ISENTRESS Breakthrough Therapy Designation Granted for MK-5172/MK-8742, in Development for the Treatment of Chronic Hepatitis C Virus Infection; V503, Mercks Investigational 9-valent HPV Vaccine has Completed Pivotal Phase III Study, on Track for 2013 Submission Narrows Full-Year Non-GAAP EPS Target to $3.48 to $3.52; GAAP EPS Target to $1.61 to $1.79 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2013.     $ in millions, except EPS amounts   ThirdQuarter2013   ThirdQuarter2012 Language: English Contact: MerckMedia Contacts:Kelley Dougherty, 908-423-4291Steven Cragle, 908-423-3461orInvestor Contacts:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results financial announces merck

 
 

Synta Announces Positive One-Year Follow-up Results for the GALAXY-1...

2013-10-27 03:04:00| Biotech - Topix.net

Synta Pharmaceuticals Corp. today announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center study designed to identify the patients with advanced non-small cell lung adenocarcinoma most likely to benefit from second-line treatment with the Company's lead drug candidate, the Hsp90 inhibitor ganetespib, in ... (more)

Tags: results positive announces followup

 

Strattec Security Corp (STRT) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

2013-10-25 09:27:22| Automakers - Topix.net

Strattec Security Corp released its earnings data on Thursday. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02, Analyst Ratings Network.com reports.

Tags: results security corp estimates

 

Kimberly-Clark Corp. (KMB) Announces Quarterly Earnings Results, Beats Expectations By $0.04 EPS

2013-10-23 07:03:35| Paper - Topix.net

Kimberly-Clark Corp. issued its quarterly earnings data on Tuesday. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04, AmericanBankingNews.com reports.

Tags: results corp expectations quarterly

 

Sites : [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] next »